WO2003064429A1 - Thienopyrimidines, procedes de fabrication et d'utilisation correspondants - Google Patents
Thienopyrimidines, procedes de fabrication et d'utilisation correspondants Download PDFInfo
- Publication number
- WO2003064429A1 WO2003064429A1 PCT/JP2003/000828 JP0300828W WO03064429A1 WO 2003064429 A1 WO2003064429 A1 WO 2003064429A1 JP 0300828 W JP0300828 W JP 0300828W WO 03064429 A1 WO03064429 A1 WO 03064429A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- alkyl
- alkylamino
- substituent
- mono
- amino
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 125000003282 alkyl amino group Chemical group 0.000 abstract 5
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 3
- 125000001424 substituent group Chemical group 0.000 abstract 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 230000008485 antagonism Effects 0.000 abstract 1
- 125000001691 aryl alkyl amino group Chemical group 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 230000001456 gonadotroph Effects 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 239000005556 hormone Substances 0.000 abstract 1
- 229940088597 hormone Drugs 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 239000003488 releasing hormone Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/502,903 US7569570B2 (en) | 2002-01-30 | 2003-01-29 | Thienopyrimidines, process for preparing the same and use thereof |
EP03734872A EP1479684A4 (en) | 2002-01-30 | 2003-01-29 | THIENOPYRIMIDINES, PROCESS FOR THEIR PRODUCTION AND THEIR USE |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002022034 | 2002-01-30 | ||
JP2002-22034 | 2002-01-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2003064429A1 true WO2003064429A1 (fr) | 2003-08-07 |
Family
ID=27654415
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2003/000828 WO2003064429A1 (fr) | 2002-01-30 | 2003-01-29 | Thienopyrimidines, procedes de fabrication et d'utilisation correspondants |
Country Status (3)
Country | Link |
---|---|
US (1) | US7569570B2 (ja) |
EP (1) | EP1479684A4 (ja) |
WO (1) | WO2003064429A1 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7300935B2 (en) | 2003-01-29 | 2007-11-27 | Takeda Pharmaceutical Company | Thienopyrimidine compounds and use thereof |
EP2881391A1 (en) | 2013-12-05 | 2015-06-10 | Bayer Pharma Aktiengesellschaft | Spiroindoline carbocycle derivatives and pharmaceutical compositions thereof |
WO2023072284A1 (zh) * | 2021-11-01 | 2023-05-04 | 山东绿叶制药有限公司 | 促性腺素释放激素拮抗剂及其制备方法和应用 |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006083005A1 (ja) * | 2005-02-03 | 2006-08-10 | Takeda Pharmaceutical Company Limited | 縮合ピリミジン誘導体およびその用途 |
US20090048273A1 (en) * | 2005-07-22 | 2009-02-19 | Takeda Pharmaceutical Company Limited | Premature ovulation preventive agent |
US8633182B2 (en) | 2012-05-30 | 2014-01-21 | Boehringer Ingelheim International Gmbh | Indanyloxyphenylcyclopropanecarboxylic acids |
SI3415517T1 (sl) | 2012-09-28 | 2022-06-30 | Takeda Pharmaceutical Company Limited | Kristalna oblika 1-(4-1-(2,6-difluorobenzil)-5-dimetilaminometil-3-(6- metoksipiridazin-3-il)-2,4-diokso-1,2,3,4-tetrahidrotieno(2,3-D)- pirimidin-6il)fenil)-3-metoksiurea |
BR112016008799B1 (pt) * | 2013-10-30 | 2023-02-23 | Shanghai Hengrui Pharmaceutical Co., Ltd. | Derivados de pirazolopirimidona ou pirrolotriazona, seus intermediários, seus usos, seus processos de preparação, e composição farmacêutica |
EP3263110B1 (en) | 2015-02-26 | 2023-05-10 | Takeda Pharmaceutical Company Limited | A tablet comprising a methoxyurea derivative and mannitol particles |
PL3518933T3 (pl) | 2016-09-30 | 2022-06-20 | Myovant Sciences Gmbh | Metody leczenia mięśniaków macicy i endometriozy |
JP7062673B2 (ja) | 2016-09-30 | 2022-05-06 | ミオバント サイエンシズ ゲーエムベーハー | 前立腺がんの治療 |
CN111943960B (zh) * | 2019-07-29 | 2022-02-15 | 广东东阳光药业有限公司 | 取代的嘧啶二酮类化合物及其用途 |
CN111574534B (zh) * | 2020-05-25 | 2021-06-04 | 东莞市东阳光新药研发有限公司 | 苯基取代的噻吩并[2,3-d]嘧啶-2,4(1H,3H)-二酮类化合物及其用途 |
CN111875614B (zh) * | 2020-07-03 | 2022-04-29 | 东莞市东阳光新药研发有限公司 | 杂环基取代的噻吩并[2,3-d]嘧啶-2,4(1H,3H)-二酮类化合物及其用途 |
CN111793078B (zh) * | 2020-07-03 | 2022-02-01 | 东莞市东阳光新药研发有限公司 | 双环含氮杂芳基取代的嘧啶二酮类化合物及其用途 |
CN111909168B (zh) * | 2020-07-31 | 2022-02-01 | 广东东阳光药业有限公司 | 含氮杂环基取代的嘧啶二酮类化合物及其用途 |
CN111925379B (zh) * | 2020-07-31 | 2022-02-15 | 广东东阳光药业有限公司 | 含氮杂芳基取代的嘧啶二酮类化合物及其用途 |
CN113754679B (zh) * | 2020-09-09 | 2023-04-07 | 广东东阳光药业有限公司 | 取代的嘧啶二酮类化合物及其用途 |
CN112047957B (zh) * | 2020-09-09 | 2022-02-01 | 广东东阳光药业有限公司 | 取代的嘧啶二酮类化合物及其用途 |
WO2022067566A1 (zh) * | 2020-09-29 | 2022-04-07 | 广东东阳光药业有限公司 | 含有饱和含氧杂环基的嘧啶二酮类化合物及其用途 |
CN112142757B (zh) * | 2020-09-29 | 2022-02-15 | 广东东阳光药业有限公司 | 五元含氮杂芳基取代的嘧啶二酮类化合物及其用途 |
CN116438181A (zh) * | 2020-09-29 | 2023-07-14 | 广东东阳光药业有限公司 | 磺酰胺基取代的杂芳基嘧啶二酮类化合物及其用途 |
Citations (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61191698A (ja) | 1985-02-08 | 1986-08-26 | メルク エンド カムパニー インコーポレーテツド | 新規な環状ヘキサペプチドlhrh拮抗剤 |
US5140009A (en) | 1988-02-10 | 1992-08-18 | Tap Pharmaceuticals, Inc. | Octapeptide LHRH antagonists |
US5171835A (en) | 1988-10-21 | 1992-12-15 | The Administrators Of The Tulane Educational Fund | LHRH antagonists |
WO1995028405A1 (en) | 1994-04-19 | 1995-10-26 | Takeda Chemical Industries, Ltd. | Bicyclic thiophene derivatives and use as gonadotropin releasing hormone antagonists |
WO1996024597A1 (en) | 1995-02-08 | 1996-08-15 | Takeda Chemical Industries, Ltd. | Thienopyrimidine derivatives, their production and use |
JPH08295693A (ja) | 1994-04-19 | 1996-11-12 | Takeda Chem Ind Ltd | 縮合チオフェン誘導体、その製造法及び用途 |
WO1997014697A1 (en) | 1995-10-19 | 1997-04-24 | Takeda Chemical Industries, Ltd. | Thienopyridine derivatives as gonadotropin releasing hormone antagonists |
WO1997014682A1 (en) | 1995-10-19 | 1997-04-24 | Takeda Chemical Industries, Ltd. | Quinoline derivatives as gnrh antagonists |
JPH09169735A (ja) | 1995-10-19 | 1997-06-30 | Takeda Chem Ind Ltd | キノリン誘導体、その製造法および用途 |
JPH09169767A (ja) | 1995-10-19 | 1997-06-30 | Takeda Chem Ind Ltd | 複素環化合物、その製造法および用途 |
JPH09208496A (ja) * | 1996-01-30 | 1997-08-12 | Takeda Chem Ind Ltd | Lh−rh拮抗物質含有組成物 |
WO1999033831A1 (en) | 1997-12-26 | 1999-07-08 | Takeda Chemical Industries, Ltd. | Nitrogen-containing heterocyclic compounds, their production and use |
JPH11315079A (ja) | 1997-12-26 | 1999-11-16 | Takeda Chem Ind Ltd | 含窒素複素環化合物、その製造法および用途 |
WO2000000493A1 (en) | 1998-06-26 | 2000-01-06 | Takeda Chemical Industries, Ltd. | Thienopyridine compounds, their production and use |
JP2000219691A (ja) | 1998-06-26 | 2000-08-08 | Takeda Chem Ind Ltd | チエノピリジン誘導体、その製造法および用途 |
WO2000056739A1 (en) | 1999-03-24 | 2000-09-28 | Takeda Chemical Industries, Ltd. | Thienopyrimidine compounds, their production and use |
WO2001007878A1 (en) | 1999-07-23 | 2001-02-01 | Shimadzu Research Laboratory (Europe) Ltd. | Apparatus and methods for analysing electromagnetic radiation |
WO2001064683A1 (fr) | 2000-02-29 | 2001-09-07 | Takeda Chemical Industries, Ltd. | Procedes de production de derives de thienopyramidine |
WO2001078780A1 (fr) * | 2000-04-13 | 2001-10-25 | Takeda Chemical Industries, Ltd. | Agents preventifs/remedes pour la maladie d'alzheimer |
WO2001095940A1 (fr) | 2000-06-14 | 2001-12-20 | Takeda Chemical Industries, Ltd. | Compositions a liberation continue |
WO2002002144A1 (en) | 2000-07-05 | 2002-01-10 | Takeda Chemical Industries, Ltd. | Medicinal preparations for treating sex hormone-dependent diseases |
JP2002030087A (ja) | 2000-07-17 | 2002-01-29 | Takeda Chem Ind Ltd | チエノピリジン−5−カルボン酸エステル化合物、その製造法および用途 |
WO2002024230A1 (fr) * | 2000-09-22 | 2002-03-28 | Takeda Chemical Industries, Ltd. | Preparations solides |
WO2002043766A1 (fr) * | 2000-11-29 | 2002-06-06 | Takeda Chemical Industries, Ltd. | Compositions medicinales et leur procede de preparation |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4316825A (en) * | 1979-10-01 | 1982-02-23 | Copolymer Rubber & Chemical Corp. | High green strength rubbers |
US6048863A (en) | 1994-04-19 | 2000-04-11 | Takeda Chemical Industries, Ltd. | Condensed-ring thiophene derivatives and thienopyrimidine derivatives, their production and use |
US6297255B1 (en) | 1998-06-26 | 2001-10-02 | Takeda Chemical Industries, Ltd. | Thienopyridine compounds, their production and use |
US6297379B1 (en) * | 1999-03-24 | 2001-10-02 | Takeda Chemical Industries, Ltd. | Thienopyrimidine compounds, their production and use |
JP2003026601A (ja) | 2000-11-29 | 2003-01-29 | Takeda Chem Ind Ltd | 医薬組成物およびその製造法 |
-
2003
- 2003-01-29 EP EP03734872A patent/EP1479684A4/en not_active Withdrawn
- 2003-01-29 WO PCT/JP2003/000828 patent/WO2003064429A1/ja active Application Filing
- 2003-01-29 US US10/502,903 patent/US7569570B2/en not_active Expired - Lifetime
Patent Citations (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61191698A (ja) | 1985-02-08 | 1986-08-26 | メルク エンド カムパニー インコーポレーテツド | 新規な環状ヘキサペプチドlhrh拮抗剤 |
US5140009A (en) | 1988-02-10 | 1992-08-18 | Tap Pharmaceuticals, Inc. | Octapeptide LHRH antagonists |
US5171835A (en) | 1988-10-21 | 1992-12-15 | The Administrators Of The Tulane Educational Fund | LHRH antagonists |
WO1995028405A1 (en) | 1994-04-19 | 1995-10-26 | Takeda Chemical Industries, Ltd. | Bicyclic thiophene derivatives and use as gonadotropin releasing hormone antagonists |
JPH08295693A (ja) | 1994-04-19 | 1996-11-12 | Takeda Chem Ind Ltd | 縮合チオフェン誘導体、その製造法及び用途 |
WO1996024597A1 (en) | 1995-02-08 | 1996-08-15 | Takeda Chemical Industries, Ltd. | Thienopyrimidine derivatives, their production and use |
JPH09169768A (ja) | 1995-02-08 | 1997-06-30 | Takeda Chem Ind Ltd | チエノピリミジン誘導体、その製造法および用途 |
WO1997014697A1 (en) | 1995-10-19 | 1997-04-24 | Takeda Chemical Industries, Ltd. | Thienopyridine derivatives as gonadotropin releasing hormone antagonists |
WO1997014682A1 (en) | 1995-10-19 | 1997-04-24 | Takeda Chemical Industries, Ltd. | Quinoline derivatives as gnrh antagonists |
JPH09169735A (ja) | 1995-10-19 | 1997-06-30 | Takeda Chem Ind Ltd | キノリン誘導体、その製造法および用途 |
JPH09169767A (ja) | 1995-10-19 | 1997-06-30 | Takeda Chem Ind Ltd | 複素環化合物、その製造法および用途 |
JPH09208496A (ja) * | 1996-01-30 | 1997-08-12 | Takeda Chem Ind Ltd | Lh−rh拮抗物質含有組成物 |
WO1999033831A1 (en) | 1997-12-26 | 1999-07-08 | Takeda Chemical Industries, Ltd. | Nitrogen-containing heterocyclic compounds, their production and use |
JPH11315079A (ja) | 1997-12-26 | 1999-11-16 | Takeda Chem Ind Ltd | 含窒素複素環化合物、その製造法および用途 |
WO2000000493A1 (en) | 1998-06-26 | 2000-01-06 | Takeda Chemical Industries, Ltd. | Thienopyridine compounds, their production and use |
JP2000219691A (ja) | 1998-06-26 | 2000-08-08 | Takeda Chem Ind Ltd | チエノピリジン誘導体、その製造法および用途 |
JP2001278884A (ja) | 1999-03-24 | 2001-10-10 | Takeda Chem Ind Ltd | チエノピリミジン化合物、その製造法および用途 |
WO2000056739A1 (en) | 1999-03-24 | 2000-09-28 | Takeda Chemical Industries, Ltd. | Thienopyrimidine compounds, their production and use |
WO2001007878A1 (en) | 1999-07-23 | 2001-02-01 | Shimadzu Research Laboratory (Europe) Ltd. | Apparatus and methods for analysing electromagnetic radiation |
WO2001064683A1 (fr) | 2000-02-29 | 2001-09-07 | Takeda Chemical Industries, Ltd. | Procedes de production de derives de thienopyramidine |
WO2001078780A1 (fr) * | 2000-04-13 | 2001-10-25 | Takeda Chemical Industries, Ltd. | Agents preventifs/remedes pour la maladie d'alzheimer |
WO2001095940A1 (fr) | 2000-06-14 | 2001-12-20 | Takeda Chemical Industries, Ltd. | Compositions a liberation continue |
WO2002002144A1 (en) | 2000-07-05 | 2002-01-10 | Takeda Chemical Industries, Ltd. | Medicinal preparations for treating sex hormone-dependent diseases |
JP2002030087A (ja) | 2000-07-17 | 2002-01-29 | Takeda Chem Ind Ltd | チエノピリジン−5−カルボン酸エステル化合物、その製造法および用途 |
WO2002024230A1 (fr) * | 2000-09-22 | 2002-03-28 | Takeda Chemical Industries, Ltd. | Preparations solides |
WO2002043766A1 (fr) * | 2000-11-29 | 2002-06-06 | Takeda Chemical Industries, Ltd. | Compositions medicinales et leur procede de preparation |
Non-Patent Citations (2)
Title |
---|
JOURNAL OF MEDICINAL CHEMISTRY, vol. 36, 1993, pages 3265 - 3273 |
SASAKI S. ET AL.: "Discovery of a thieno(2,3-d) pyrimidine-2,4-dione bearing a P-methoxyureidophenyl moiety at the 6-position: ....... a antagonist for the human lutenizing .........", J. MED. CHEM., vol. 46, no. 1, 2 January 2003 (2003-01-02), pages 113 - 124, XP002967759 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7300935B2 (en) | 2003-01-29 | 2007-11-27 | Takeda Pharmaceutical Company | Thienopyrimidine compounds and use thereof |
US8058280B2 (en) | 2003-01-29 | 2011-11-15 | Takeda Pharmaceutical Company Limited | Substituted thieno[2,3-d]pyrimidin-2,4-dione compounds and uses thereof |
US8735401B2 (en) | 2003-01-29 | 2014-05-27 | Takeda Pharmaceutical Company Limited | Thienopyrimidine compounds and use thereof |
US9346822B2 (en) | 2003-01-29 | 2016-05-24 | Takeda Pharmaceutical Company Limited | Thienopyrimidine compounds and use thereof |
EP2881391A1 (en) | 2013-12-05 | 2015-06-10 | Bayer Pharma Aktiengesellschaft | Spiroindoline carbocycle derivatives and pharmaceutical compositions thereof |
WO2023072284A1 (zh) * | 2021-11-01 | 2023-05-04 | 山东绿叶制药有限公司 | 促性腺素释放激素拮抗剂及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
US20050222174A1 (en) | 2005-10-06 |
EP1479684A4 (en) | 2006-01-04 |
EP1479684A1 (en) | 2004-11-24 |
US7569570B2 (en) | 2009-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003064429A1 (fr) | Thienopyrimidines, procedes de fabrication et d'utilisation correspondants | |
MXPA02011974A (es) | Derivados de quinazolina sustituidos y su uso como inhibidores. | |
WO2001002400A8 (fr) | Composes imidazole fusionnes et medicaments contre le diabete sucre | |
CA2311742A1 (en) | 6-amino-9-benzyl-8-hydroxypurine derivatives | |
WO2003050087A3 (en) | Novel herbicides | |
GB0206860D0 (en) | Compounds | |
EP1674452A4 (en) | NOVEL 4-PHENYLAMINO-BENZALDOXIME DERIVATIVE AND ITS USE AS MEK INHIBITOR | |
TW200510431A (en) | Quinazoline derivatives | |
UA83091C2 (en) | Pyrido[2,3-d]pyrimidine-2,4-diamines as pde 2 inhibitors | |
GB0004888D0 (en) | Chemical compounds | |
WO2003091232A3 (en) | Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them | |
WO2004002981A3 (en) | Herbicidal thienylalkynes | |
WO2006005609A3 (de) | Substituierte oxindol-derivate und diese enthaltende arzneimittel | |
NO20052074L (no) | Substituerte benzoksazinoner og anvendelser derav. | |
WO2005105096A3 (en) | Fused heterocyclic compounds | |
NO20052182L (no) | Nye forbindelser | |
WO2001062705A3 (en) | Aminoalcohol derivatives | |
GEP20074125B (en) | Pyrazolopyridines and methods of making and using the same | |
AU1247195A (en) | Cyclic amide derivatives as neurokinin a antagonists | |
WO2004014868A3 (en) | Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors | |
WO2003053971A8 (en) | Pyridoquinoxaline antivirals | |
EP1553096A4 (en) | pyrazole | |
WO2004014389A8 (en) | 3,4-dihydroquinolin-2-one, 5,6-fused oxazin-3-one, and 5,6-fused thiazin-3-one derivatives as matrix metalloproteinase inhibitors | |
WO2003031414A1 (fr) | Nouveau compose heterocyclique et agent anti-inflammatoire | |
WO2001010860A3 (en) | Quinazolinone and azaquinazolinone derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 10502903 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003734872 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2003734872 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |